Answer
Breastfeeding must be stopped before Trisenox (arsenic trioxide) administration, throughout treatment and for two weeks after the last dose because arsenic enters human milk and may cause serious adverse reactions in breastfed infants and children.
Sources for this answer
- Trisenox (arsenic trioxide) 2mg/ml Concentrate for Solution for InfusionTeva Pharma B.V. · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked